1-2 of 2
Keywords: Carbimazole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamic Changes in Soluble Interleukin-2 Receptor Levels during Treatment of Graves’ Disease: Correlation with Disease Activity

Subject Area:
Endocrinology , Women's and Children's Health
Georges Weryha, Bernard Gobert, Jacques Leclère, Marie-Christine Beĭneĭ, Gilbert Faure, Pierre Hartemann
Journal: Hormone Research in Paediatrics
Hormone Research (1991) 35 (1): 8–12.
https://doi.org/10.1159/000181868
Published Online: 02 December 2008
... in sIL-2R levels was performed in the serum of 10 patients undergoing a medical treatment for Graves’ disease. All patients received carbimazole during the study and, when necessary, L -thyroxine to compensate hypothyroidism. sIL-2R levels were measured before (M0) and after the 1st (M1), 3rd (M3...
View articletitled, Dynamic Changes in Soluble Interleukin-2 Receptor Levels during Treatment of Graves’ Disease: Correlation with Disease Activity
Open the PDF for Dynamic Changes in Soluble Interleukin-2 Receptor Levels during Treatment of Graves’ Disease: Correlation with Disease Activity in another window
Journal Articles

Hepatotoxicity from Antithyroid Drugs

Subject Area:
Endocrinology , Women's and Children's Health
Angelica C. Vitug, Joel M. Goldman
Journal: Hormone Research in Paediatrics
Hormone Research (1985) 21 (4): 229–234.
https://doi.org/10.1159/000180054
Published Online: 26 November 2008
...Angelica C. Vitug; Joel M. Goldman We review the cases of hepatic injury from propylthiouracil, methimazole and carbimazole in the English language literature and compare them to cases of agranulocytosis in a recent review. The data on hepatotoxicity confirm the findings for agranulocytosis...
View articletitled, Hepatotoxicity from Antithyroid Drugs
Open the PDF for Hepatotoxicity from Antithyroid Drugs in another window